Carregant...
Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
IMPORTANCE: While there have been multiple assessments of clinical trials leading to anticancer drug approvals by the US Food and Drug Administration (FDA), the cumulative percentage of approvals based on trials with a limitation remains uncertain. OBJECTIVE: To assess the percentage of clinical tri...
Guardat en:
| Publicat a: | JAMA Intern Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Medical Association
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296449/ https://ncbi.nlm.nih.gov/pubmed/32539071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.2250 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|